Actinogen Medical Limited has released a press release.
ACW unlisted options fully underwritten
Earlier from Actinogen Medical
- ACW FY2026 results and outlook
- June 2026 Quarterly activity report & Appendix 4C
- Xanamem depression trial published in British J Psychiatry
- ACW third positive XanaMIA trial data committee review